Filter
712
Filtered Results: 712
Text search:
National
Centre
for
Disease
Control
-
Delhi
Featured
Recommendations
66
New Publications
239
Language
Document type
No document type
432
Guidelines
104
Studies & Reports
99
Manuals
39
Strategic & Response Plan
13
Training Material
11
Fact sheets
7
Situation Updates
4
Infographics
3
Countries / Regions
India
254
Global
23
Nepal
21
South–East Asia Region
19
Asia
17
Bangladesh
8
Kenya
7
Myanmar / Burma
7
Thailand
4
South Africa
4
Africa
4
Russia
4
Ethiopia
3
Tanzania
3
Cambodia
3
Mozambique
3
Ukraine
3
Eastern Europe
3
Ghana
2
Philippines
2
South Sudan
2
China
2
Indonesia
2
Namibia
2
Brazil
2
Latin America and the Carribbean
2
Laos
2
Vietnam
2
Sierra Leone
1
Liberia
1
Nigeria
1
Senegal
1
Guinea-Bissau
1
USA
1
Haiti
1
Somalia
1
Pakistan
1
Jordan
1
Afghanistan
1
Rwanda
1
Benin
1
Colombia
1
Libya
1
Angola
1
Sri Lanka
1
East and Southern Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Bhutan
1
Qatar
1
Kazakhstan
1
Georgia
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
309
Clinical Guidelines
76
Public Health
54
Women & Child Health
30
Key Resources
23
Pharmacy & Technologies
8
Capacity Building
6
Toolboxes
TB
55
HIV
41
Mental Health
40
AMR
40
COVID-19
32
NTDs
32
Caregiver
29
Rapid Response
24
Planetary Health
19
Disability
15
Global Health Education
15
NCDs
14
Pharmacy
12
Natural Hazards
6
Refugee
6
Ebola
5
Specific Hazards
5
Zika
4
Polio
2
Social Ethics
2
Cholera
1
Health Financing Toolbox
1
Hand hygiene is vital for safe health care delivery, yet practices at the point of care remain suboptimal worldwide. A comprehensive research agenda is therefore necessary to improve our understanding of factors influencing hand hygiene behaviour an...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock...
Global cardiovascular disease (CVD) burden is high and rising, especially in low-income and middle-income countries (LMICs). Focussing on 45 LMICs, we aimed to determine (1) the adult population’s median 10-year predicted CVD risk, including its v...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients ...
Improving Infection Prevention and Control Practices at Health Facilities in Resource-Limited Settings
recommended
SIAPS Technical Report. This report summarizes key accomplishments and lessons learned in implementing SIAPS’ approach to improving IPC practices in four countries: South Africa, Namibia, Jordan, and Ethiopia. All activities address SIAPS’s overall objective to build or enhance ... and facility capacity to develop, implement, and monitor IPC programs by focusing on the principles of health systems strengthening.
This document sets out the criteria and procedures to be followed by countries in verifying the interruption of yaws transmission. It is intended for use by international verification teams, national...
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by n... yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide technical support to countries in the eradication of yaws.
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread,...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these c...
he WHO Guidelines on Integrated Care for Older People (ICOPE) propose evidence-based recommendations for health care professionals to prevent, slow or reverse declines in the physical and mental cap...
For biological agents, the publication covers 11 bacteria,
fungi and viruses listed by states parties to the Biological
Weapons Convention in declarations of past offensive
research and development programmes, or considered of
special concern ... possible use in terrorism. All of these
agents can cause natural disease in humans, though with
markedly different frequency.
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorde...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not...
The Global Sexual and Reproductive Health Service Package for Men and Adolescent Boys has been developed to support providers of sexual and reproductive health (SRH) services to increase the range and quality of services to meet the specific and div...
The report is geared towards mayors, local government officials and city policy planners.It highlights key areas where city leaders can tackle the drivers of NCDs, including tobacco use, air pollution, poor diets and lack of exercise, and improve road safety.
From anti-tobacco actions in Beijing a...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and thr...
These guidelines deal specifically with water, sanitation and hygiene, and are designed to be used in schools in low-cost settings in low- and medium-resource countries to:
• assess prevailing situations and plan for required improvements;
• ...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access ... clarity. The publication of the RECOVERY and REMAP-CAP randomised controlled trials triggered this guideline update, resulting in a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19.
Prior recommendations: (a) A recommendation not to use ivermectin in patients with covid-19, regardless of disease severity, except in the context of a clinical trial; (b) a strong recommendation against the use of hydroxychloroquine in patients with covid-19, regardless of disease severity; (c) a strong recommendation against the use of lopinavir-ritonavir in patients with covid-19, regardless of disease severity; (d) a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19; (e) a conditional recommendation against systemic corticosteroids in patients with non-severe covid-19; and (f) a conditional recommendation against remdesivir in hospitalised patients with covid-19.
The WHO Guidance on community mental health services: Promoting person-centred and rights-based approaches document is part of the WHO Guidance and technical packages on community mental health services set of publications. It provides a detailed description of person-centred and human rights-based ...
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have de...
